"Designing Growth Strategies is in our DNA"

Anxiety Disorders and Depression Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Antidepressants, Anxiolytics, Anticonvulsants, Noradrenergic Agents, and Atypical Antipsychotics), By Indication (Anxiety and Depression), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI102787

 

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Anxiety & Depression –Key Regions/Country
    2. New Product Launch
    3. Pipeline Analysis
    4. Impact of COVID-19 on the Anxiety Disorders and Depression Treatment Market
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  5. Global Anxiety Disorders and Depression Treatment Market  Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Antidepressants
      2. Anxiolytics
      3. Anticonvulsants
      4. Noradrenergic Agents
      5. Atypical Antipsychotics
    3. Market Analysis, Insights and Forecast – By Indication
      1. Anxiety
      2. Depression
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Anxiety Disorders and Depression Treatment Market  Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Antidepressants
      2. Anxiolytics
      3. Anticonvulsants
      4. Noradrenergic Agents
      5. Atypical Antipsychotics
    3. Market Analysis, Insights and Forecast – By Indication
      1. Anxiety
      2. Depression
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Indication
          1. Anxiety
          2. Depression
      2. Canada
        1. By Indication
          1. Anxiety
          2. Depression
  7. Europe Anxiety Disorders and Depression Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Antidepressants
      2. Anxiolytics
      3. Anticonvulsants
      4. Noradrenergic Agents
      5. Atypical Antipsychotics
    3. Market Analysis, Insights and Forecast – By Indication
      1. Anxiety
      2. Depression
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
        1. By Indication
          1. Anxiety
          2. Depression
      2. Germany
        1. By Indication
          1. Anxiety
          2. Depression
      3. France
        1. By Indication
          1. Anxiety
          2. Depression
      4. Spain
        1. By Indication
          1. Anxiety
          2. Depression
      5. Italy
        1. By Indication
          1. Anxiety
          2. Depression
      6. Scandinavia
        1. By Indication
          1. Anxiety
          2. Depression
      7. Rest of Europe
        1. By Indication
          1. Anxiety
          2. Depression
  8. Asia Pacific Anxiety Disorders and Depression Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Antidepressants
      2. Anxiolytics
      3. Anticonvulsants
      4. Noradrenergic Agents
      5. Atypical Antipsychotics
    3. Market Analysis, Insights and Forecast – By Indication
      1. Anxiety
      2. Depression
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Indication
          1. Anxiety
          2. Depression
      2. China
        1. By Indication
          1. Anxiety
          2. Depression
      3. India
        1. By Indication
          1. Anxiety
          2. Depression
      4. Australia
        1. By Indication
          1. Anxiety
          2. Depression
      5. Southeast Asia
        1. By Indication
          1. Anxiety
          2. Depression
      6. Rest of Asia Pacific
        1. By Indication
          1. Anxiety
          2. Depression
  9. Latin America Anxiety Disorders and Depression Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Antidepressants
      2. Anxiolytics
      3. Anticonvulsants
      4. Noradrenergic Agents
      5. Atypical Antipsychotics
    3. Market Analysis, Insights and Forecast – By Indication
      1. Anxiety
      2. Depression
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
        1. By Indication
          1. Anxiety
          2. Depression
      2. Mexico
        1. By Indication
          1. Anxiety
          2. Depression
      3. Rest of Latin America
        1. By Indication
          1. Anxiety
          2. Depression
  10. Middle East & Africa Anxiety Disorders and Depression Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Antidepressants
      2. Anxiolytics
      3. Anticonvulsants
      4. Noradrenergic Agents
      5. Atypical Antipsychotics
    3. Market Analysis, Insights and Forecast – By Indication
      1. Anxiety
      2. Depression
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
        1. By Indication
          1. Anxiety
          2. Depression
      2. South Africa
        1. By Indication
          1. Anxiety
          2. Depression
      3. Rest of Middle East & Africa
        1. By Indication
          1. Anxiety
          2. Depression
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Company Profiles
      1. Pfizer Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. H. Lundbeck A/S
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. GlaxoSmithKline plc
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Merck & Co. Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Eli Lilly and Company
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Johnson & Johnson
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. AztraZeneca
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Bristol-Myers Squibb
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Other Prominent Players
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  12. Strategic Recommendations
Read Less

Figure 01: Global Anxiety Disorders and Depression Treatment Market Value Share (%), by Region, 2019 & 2027

Figure 02: Global Anxiety Disorders and Depression Treatment Market Value Share (%), By Drug Class, 2019 & 2027

Figure 03: Global Anxiety Disorders and Depression Treatment Market Forecast (USD Billion), By Antidepressants, 2016 -2027

Figure 04: Global Anxiety Disorders and Depression Treatment Market Forecast (USD Billion), By Anxiolytics, 2016 -2027

Figure 05: Global Anxiety Disorders and Depression Treatment Market Forecast (USD Billion), By Anticonvulsants, 2016 -2027

Figure 06: Global Anxiety Disorders and Depression Treatment Market Forecast (USD Billion), By Noradrenergic Agents, 2016 -2027

Figure 07: Global Anxiety Disorders and Depression Treatment Market Forecast (USD Billion), By Atypical antipsychotics, 2016 -2027

Figure 08: Global Anxiety Disorders and Depression Treatment Market Value Share (%), By Indication, 2019 & 2027

Figure 09: Global Anxiety Disorders and Depression Treatment Market Forecast (USD Billion), By Anxiety, 2016 -2027

Figure 10: Global Anxiety Disorders and Depression Treatment Market Forecast (USD Billion), By Depression, 2016 -2027

Figure 11: Global Anxiety Disorders and Depression Treatment Market Value Share (%), By Distribution Channel, 2019 & 2027

Figure 12: Global Anxiety Disorders and Depression Treatment Market Forecast (USD Billion), By Hospital Pharmacy, 2016 -2027

Figure 13: Global Anxiety Disorders and Depression Treatment Market Forecast (USD Billion), By Retail Pharmacy, 2016 -2027

Figure 14: Global Anxiety Disorders and Depression Treatment Market Forecast (USD Billion), By Online Pharmacy, 2016 -2027

Figure 15: North America Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Country, 2019 & 2027

Figure 16: North America Anxiety Disorders and Depression Treatment Market Value Share (%), By Country, 2019

Figure 17: North America Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Drug Class, 2019 & 2027

Figure 18: North America Anxiety Disorders and Depression Treatment Market Value Share (%), By Drug Class, 2019

Figure 19: North America Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Indication, 2019 & 2027

Figure 20: North America Anxiety Disorders and Depression Treatment Market Value Share (%), By Indication, 2019

Figure 21: North America Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Distribution Channel, 2019 & 2027

Figure 22: North America Anxiety Disorders and Depression Treatment Market Value Share (%), By Distribution Channel, 2019

Figure 23: Europe Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Country, 2019 & 2027

Figure 24: Europe Anxiety Disorders and Depression Treatment Market Value Share (%), By Country, 2019

Figure 25: Europe Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Drug Class, 2019 & 2027

Figure 26: Europe Anxiety Disorders and Depression Treatment Market Value Share (%), By Drug Class, 2019

Figure 27: Europe Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Indication, 2019 & 2027

Figure 28: Europe Anxiety Disorders and Depression Treatment Market Value Share (%), By Indication, 2019

Figure 29: Europe Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Distribution Channel, 2019 & 2027

Figure 30: Europe Anxiety Disorders and Depression Treatment Market Value Share (%), By Distribution Channel, 2019

Figure 31: Asia Pacific Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Country, 2019 & 2027

Figure 32: Asia Pacific Anxiety Disorders and Depression Treatment Market Value Share (%), By Country, 2019

Figure 33: Asia Pacific Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Drug Class, 2019 & 2027

Figure 34: Asia Pacific Anxiety Disorders and Depression Treatment Market Value Share (%), By Drug Class, 2019

Figure 35: Asia Pacific Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Indication, 2019 & 2027

Figure 36: Asia Pacific Anxiety Disorders and Depression Treatment Market Value Share (%), By Indication, 2019

Figure 37: Asia Pacific Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Distribution Channel, 2019 & 2027

Figure 38: Asia Pacific Anxiety Disorders and Depression Treatment Market Value Share (%), By Distribution Channel, 2019

Figure 39: Latin America Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Country, 2019 & 2027

Figure 40: Latin America Anxiety Disorders and Depression Treatment Market Value Share (%), By Country, 2019

Figure 41: Latin America Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Drug Class, 2019 & 2027

Figure 42: Latin America Anxiety Disorders and Depression Treatment Market Value Share (%), By Drug Class, 2019

Figure 43: Latin America Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Indication, 2019 & 2027

Figure 44: Latin America Anxiety Disorders and Depression Treatment Market Value Share (%), By Indication, 2019

Figure 45: Latin America Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Distribution Channel, 2019 & 2027

Figure 46: Latin America Anxiety Disorders and Depression Treatment Market Value Share (%), By Distribution Channel, 2019

Figure 47: Middle East & Africa Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Country, 2019 & 2027

Figure 48: Middle East & Africa Anxiety Disorders and Depression Treatment Market Value Share (%), By Country, 2019

Figure 49: Middle East & Africa Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Drug Class, 2019 & 2027

Figure 50: Middle East & Africa Anxiety Disorders and Depression Treatment Market Value Share (%), By Drug Class, 2019

Figure 51: Middle East & Africa Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Indication, 2019 & 2027

Figure 52: Middle East & Africa Anxiety Disorders and Depression Treatment Market Value Share (%), By Indication, 2019

Figure 53: Middle East & Africa Anxiety Disorders and Depression Treatment Market Value (USD Billion), By Distribution Channel, 2019 & 2027

Figure 54: Middle East & Africa Anxiety Disorders and Depression Treatment Market Value Share (%), By Distribution Channel, 2019

Figure 55: Global Anxiety Disorders and Depression Treatment Market Revenue (%) Share Analysis by Key Players, 2019

Table 1: Global Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Region, 2016–2027

Table 2: Global Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016–2027

Table 3: Global Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Indication, 2016–2027

Table 4: Global Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016–2027

Table 5: North America Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Country, 2016–2027

Table 6: North America Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016–2027

Table 7: North America Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Indication, 2016–2027

Table 8: North America Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016–2027

Table 9: Europe Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Country, 2016–2027

Table 10: Europe Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016–2027

Table 11: Europe Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Indication, 2016–2027

Table 12: Europe Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016–2027

Table 13: Asia Pacific Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Country, 2016–2027

Table 14: Asia Pacific Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016–2027

Table 15: Asia Pacific Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Indication, 2016–2027

Table 16: Asia Pacific Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016–2027

Table 17: Latin America Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Country, 2016–2027

Table 18: Latin America Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016–2027

Table 19: Latin America Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Indication, 2016–2027

Table 20: Latin America Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016–2027

Table 21: Middle East & Africa Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Country, 2016–2027

Table 22: Middle East & Africa Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016–2027

Table 23: Middle East & Africa Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Indication, 2016–2027

Table 24: Middle East & Africa Anxiety Disorders and Depression Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016–2027

Booklet
  • Jan, 2021
  • 2019
  • 2016-2018
  • 135

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X